Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA brivanib CTRPv2 pan-cancer AAC 0.076 0.03
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.074 0.03
mRNA Irinotecan gCSI pan-cancer AAC -0.12 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.075 0.03
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.07 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.03
mRNA BRD-K34099515 CTRPv2 pan-cancer AAC 0.16 0.03
mRNA azacitidine CTRPv2 pan-cancer AAC 0.079 0.03
mRNA MS-275 CTRPv2 pan-cancer AAC 0.067 0.04
Download CSV